Brief: Cipher Pharmaceuticals Announces Automatic Repurchase Plan Pursuant To Its Normal Course Issuer Bid
25/03/2021 11:26
March 25 (Reuters) - Cipher Pharmaceuticals Inc CPH.TO :
* CIPHER PHARMACEUTICALS ANNOUNCES AUTOMATIC REPURCHASE PLAN
PURSUANT TO ITS NORMAL COURSE ISSUER BID
Source text for Eikon: ID:nCNWTxlcta
Further company coverage: CPH.TO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cipher Pharmaceuticals
See all newsBrief: Cipher Pharmaceuticals Receives Favourable Decision Confirming Arbitration Award
Canada's Cipher Pharma Q2 revenue falls on lower Natroba sales amid reduced Medicaid coverage
Canada Research Roundup: Altius Minerals, Cipher Pharmaceuticals, Suncor Energy
Canada's Cipher Pharmaceuticals Q1 net income jumps 135% on lower costs
Brief: Cipher Pharmaceuticals Q1 Net Income USD 6.163 Million